FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113488110> ?p ?o ?g. }

• W2113488110 abstract "Often affecting knee joints, osteoarthritis (OA) is the most common type of arthritis and by 2020 is predicted to become the fourth leading cause of disability globally. Without cure, medication management is symptomatic, mostly with simple analgesics such as acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs), and glucosamine sulfate. Adherence to arthritis medications is generally low. Intentional non-adherence, that is deliberate decision-making about the use of analgesics, occurs in OA patients. To date, a limited number of studies have explored medication-taking decisions in people with OA nor the extent to which individuals' trade off one treatment factor for another in their decision-making using quantitative techniques. This study aimed to estimate the relative influence of medication-related factors and respondent characteristics on decisions to continue medications among people with symptomatic OA.A discrete choice experiment (DCE) was conducted among participants attending end-of-study visits in the Long-term Evaluation of Glucosamine Sulfate (LEGS) study (ClinicalTrials.gov ID: NCT00513422). The paper-based survey was used to estimate the relative importance of seven medication specific factors (pain efficacy, mode of action, dose frequency, treatment schedule, side effects, prescription, and out-of-pocket costs) and respondent characteristics on decisions to continue medications.188 (response rate 37%) completed surveys were returned. Four of the seven medication factors (side effects, out-of-pocket costs, mode of action, treatment schedule) had a significant effect on the choice to continue medication; patient characteristics did not. Assuming equivalent pain efficacy and disease-modifying properties for glucosamine, the positive relative likelihood of continuing with sustained-release acetaminophen was equivalent to glucosamine. By contrast, the negative relative likelihood of NSAID continuation was mostly driven by the side effect profile. The predicted probability of continuing with glucosamine decreased with increasing out-of-pocket costs.This study has characterised the complexity of medication-taking decisions that potentially underpin intentional non-adherent behaviour for people with symptomatic OA. In particular, medication risks and cost were important and ought to be borne into considerations in interpreting clinical trial evidence for practice. Ultimately addressing these factors may be the way forward to realising the full potential of health and economic benefits from the efficacious and safe use of OA medications." @default.
• W2113488110 created "2016-06-24" @default.
• W2113488110 creator A5004641212 @default.
• W2113488110 creator A5011311836 @default.
• W2113488110 creator A5015188988 @default.
• W2113488110 creator A5083333103 @default.
• W2113488110 date "2013-05-06" @default.
• W2113488110 modified "2023-10-14" @default.
• W2113488110 title "Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS)" @default.
• W2113488110 cites W1932441487 @default.
• W2113488110 cites W1967768876 @default.
• W2113488110 cites W1974837476 @default.
• W2113488110 cites W1975928343 @default.
• W2113488110 cites W1986908357 @default.
• W2113488110 cites W1995005198 @default.
• W2113488110 cites W2000546170 @default.
• W2113488110 cites W2001028482 @default.
• W2113488110 cites W2014700506 @default.
• W2113488110 cites W2023279674 @default.
• W2113488110 cites W2033664113 @default.
• W2113488110 cites W2036310725 @default.
• W2113488110 cites W2036491373 @default.
• W2113488110 cites W2037687999 @default.
• W2113488110 cites W2040717958 @default.
• W2113488110 cites W2093467067 @default.
• W2113488110 cites W2102156320 @default.
• W2113488110 cites W2103735303 @default.
• W2113488110 cites W2105539104 @default.
• W2113488110 cites W2116022271 @default.
• W2113488110 cites W2121619367 @default.
• W2113488110 cites W2122119377 @default.
• W2113488110 cites W2122707212 @default.
• W2113488110 cites W2126411471 @default.
• W2113488110 cites W2135168058 @default.
• W2113488110 cites W2136672644 @default.
• W2113488110 cites W2146385165 @default.
• W2113488110 cites W2147574815 @default.
• W2113488110 cites W2155441883 @default.
• W2113488110 cites W2156737403 @default.
• W2113488110 cites W2165447178 @default.
• W2113488110 cites W3125291297 @default.
• W2113488110 cites W3152367353 @default.
• W2113488110 cites W4252978187 @default.
• W2113488110 doi "https://doi.org/10.1186/1471-2474-14-160" @default.
• W2113488110 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3660275" @default.
• W2113488110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23647688" @default.
• W2113488110 hasPublicationYear "2013" @default.
• W2113488110 type Work @default.
• W2113488110 sameAs 2113488110 @default.
• W2113488110 citedByCount "73" @default.
• W2113488110 countsByYear W21134881102014 @default.
• W2113488110 countsByYear W21134881102015 @default.
• W2113488110 countsByYear W21134881102016 @default.
• W2113488110 countsByYear W21134881102017 @default.
• W2113488110 countsByYear W21134881102018 @default.
• W2113488110 countsByYear W21134881102019 @default.
• W2113488110 countsByYear W21134881102020 @default.
• W2113488110 countsByYear W21134881102021 @default.
• W2113488110 countsByYear W21134881102022 @default.
• W2113488110 countsByYear W21134881102023 @default.
• W2113488110 crossrefType "journal-article" @default.
• W2113488110 hasAuthorship W2113488110A5004641212 @default.
• W2113488110 hasAuthorship W2113488110A5011311836 @default.
• W2113488110 hasAuthorship W2113488110A5015188988 @default.
• W2113488110 hasAuthorship W2113488110A5083333103 @default.
• W2113488110 hasBestOaLocation W21134881101 @default.
• W2113488110 hasConcept C126322002 @default.
• W2113488110 hasConcept C142724271 @default.
• W2113488110 hasConcept C17744445 @default.
• W2113488110 hasConcept C1862650 @default.
• W2113488110 hasConcept C199539241 @default.
• W2113488110 hasConcept C204787440 @default.
• W2113488110 hasConcept C2426938 @default.
• W2113488110 hasConcept C2776164576 @default.
• W2113488110 hasConcept C2776640315 @default.
• W2113488110 hasConcept C2778722691 @default.
• W2113488110 hasConcept C42219234 @default.
• W2113488110 hasConcept C71924100 @default.
• W2113488110 hasConcept C98274493 @default.
• W2113488110 hasConceptScore W2113488110C126322002 @default.
• W2113488110 hasConceptScore W2113488110C142724271 @default.
• W2113488110 hasConceptScore W2113488110C17744445 @default.
• W2113488110 hasConceptScore W2113488110C1862650 @default.
• W2113488110 hasConceptScore W2113488110C199539241 @default.
• W2113488110 hasConceptScore W2113488110C204787440 @default.
• W2113488110 hasConceptScore W2113488110C2426938 @default.
• W2113488110 hasConceptScore W2113488110C2776164576 @default.
• W2113488110 hasConceptScore W2113488110C2776640315 @default.
• W2113488110 hasConceptScore W2113488110C2778722691 @default.
• W2113488110 hasConceptScore W2113488110C42219234 @default.
• W2113488110 hasConceptScore W2113488110C71924100 @default.
• W2113488110 hasConceptScore W2113488110C98274493 @default.
• W2113488110 hasIssue "1" @default.
• W2113488110 hasLocation W21134881101 @default.
• W2113488110 hasLocation W21134881102 @default.
• W2113488110 hasLocation W21134881103 @default.
• W2113488110 hasLocation W21134881104 @default.
• W2113488110 hasLocation W21134881105 @default.
• W2113488110 hasOpenAccess W2113488110 @default.
• W2113488110 hasPrimaryLocation W21134881101 @default.

• next